
-
Only man to appeal in Gisele Pelicot case says not a 'rapist'
-
Appetite-regulating hormones in focus as first Nobel Prizes fall
-
Gisele Pelicot: French rape survivor and global icon
-
Negotiators due in Egypt for Gaza talks as Trump urges quick action
-
'My heart sank': Surging scams roil US job hunters
-
Competition heats up to challenge Nvidia's AI chip dominance
-
UK police to get greater powers to restrict demos
-
Guerrero grand slam fuels Blue Jays in 13-7 rout of Yankees
-
Five-try Bayonne stun champions Toulouse to go top in France
-
Fisk reels in Higgo to win maiden PGA Tour title in Mississippi
-
Aces overpower Mercury for 2-0 lead in WNBA Finals
-
Bayonne stun champions Toulouse to go top in France
-
Greta Thunberg among Gaza flotilla detainees to leave Israel
-
Atletico draw at Celta Vigo after Lenglet red card
-
Trump administration brands US cities war zones
-
Ethan Mbappe returns to haunt PSG as Lille force draw with Ligue 1 leaders
-
Hojlund fires Napoli into Serie A lead as AC Milan held at Juve
-
Vampires, blood and dance: Bollywood horror goes mainstream
-
Broncos rally snaps Eagles unbeaten record, Ravens slump deepens
-
Former NFL QB Sanchez charged after allegedly attacking truck driver
-
France unveils new government amid political deadlock
-
Hojlund fires Napoli into Serie A lead ahead of AC Milan's showdown with Juve
-
Child's play for Haaland as Man City star strikes again
-
India crush Pakistan by 88 runs amid handshake snub, umpiring drama
-
Hojlund fires Napoli past Genoa and into Serie A lead
-
Sevilla rout 'horrendous' Barca in Liga thrashing
-
Haaland fires Man City to win at Brentford, Everton end Palace's unbeaten run
-
Haaland extends hot streak as Man City sink Brentford
-
Italy working hard to prevent extra US tariffs on pasta
-
Sinner out of Shanghai Masters as Djokovic battles into last 16
-
Swift rules N. America box office with 'Showgirl' event
-
Ryder Cup hero MacIntyre wins Alfred Dunhill Links on home soil
-
Republicans warn of pain ahead as US shutdown faces second week
-
Sevilla rout champions Barca in shock Liga thrashing
-
Norris-Piastri clash overshadows McLaren constructors' title win
-
Trump administration declares US cities war zones
-
Bad Bunny takes aim at Super Bowl backlash in 'SNL' host gig
-
El Khannouss fires Stuttgart into Bundesliga top four
-
Insatiable Pogacar romps to European title
-
Newcastle inflict more pain on Postecoglou, Everton end Palace's unbeaten run
-
Daryz wins emotional and thrilling Prix de l'Arc de Triomphe
-
US Open finalist Anisimova wins Beijing title in 'great year'
-
Daryz wins Prix de l'Arc de Triomphe thriller
-
Russell wins Singapore GP as McLaren seal constructors' title
-
Landslides and floods kill 64 in Nepal, India
-
Russell wins Singapore GP, McLaren seal constructors' title
-
Djokovic 'hangs by rope' before battling into Shanghai last 16
-
Erasmus proud of Boks' title triumph as Rugby Championship faces uncertain future
-
US Open finalist Anisimova caps breakthrough year with Beijing title
-
French PM under pressure to put together cabinet

Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets
ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic milestone towards expanding its commercial footprint and building significant shareholder value. The company has filed a new Provisional Patent (#63/877,517) that embodies a groundbreaking method for loading Extracellular Vesicles (EVs). This technological innovation is poised to give the company a significant competitive advantage.
The new provisional patent, which will be utilized under the company's Exousia Health division, covers a novel process for encapsulating active compounds into tiny, naturally-secreted vesicles known as exosomes. This method is designed to enhance loading efficiency and improve the stability and delivery of therapeutic agents. This technology has wide-ranging applications across three enormous markets:
Pharmaceuticals: The global pharmaceutical market is a multi-trillion dollar industry, with an estimated size of $1.77 trillion in 2025.
Nutraceuticals: The global nutraceuticals market is valued at over $500 billion in 2025.
Cosmetics: The global cosmetics market is also a multi-billion dollar industry, valued at over $450 billion in 2025.
"The filing of this provisional patent marks a pivotal moment for Exousia Pro, as it represents one of two new patent-ready technologies we have in development," said Matt Dwyer, President of Exousia Pro, Inc. "This proprietary technology is a critical asset that will provide us with a powerful market edge. It will enable us to develop and introduce new, innovative products with enhanced efficacy for our growing patient base within Exousia Health, and beyond. We are actively preparing to file for trademarks on several new products that will leverage this loading method, further expanding our revenue opportunities and bringing tangible value to our shareholders."
About Us
Exousia Pro (formerly Marijuana, Inc.) is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology.The company's patented manufacturing process utilizes plant-based materials to create exosomes used in a number of commercial applications, from dermatology to dentistry. The company's proprietary loading technology can infuse a range of molecules from drugs to DNA.
For more information, please visit: www.exousiapro.com
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Exousia Pro, Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the parties' future level of business. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Exousia Pro, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
CONTACT:
Exousia Pro, Inc.
www.Exousiapro.com
Twitter: @Exousia_Pro
Investor Relations
[email protected]
SOURCE: Exousia Pro, Inc.
View the original press release on ACCESS Newswire
C.Garcia--AMWN